Guillain-Barre Syndrome
NEJM 366:2294-2304, Yuki, N. & Hartung, H.P., 2012
Acute Neuromuscular Respiratory Paralysis
JNNP 56:334-343, Hughes,R.A.C.&Bihari,D., 1993
Intensive Management and Treatment of Severe Guillain-Barre Syndrome
Crit Care Med 21:433-446, Hund,E.F.,et al, 1993
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
A Rare Case of Bilateral Optic Neuritis and Guillain-Barre Syndrome Post Mycoplasma Pneumoniae Infection
Neuro Opth 41:41-47, Baheerathan, A.,et al, 2017
Evidence-based Guideline: Intravenous Immunoglobulin in the Treatment of Neuromascular Disorders
Neurol 78:1009-1015, Patwa,H.S.,et al, 2012
Morvan Syndrome: Clinical and Serological Observations in 29 Cases
Ann Neurol 72:241-255, Irani, S.R.,et al, 2012
Evidence-Based Guideline Update: Plasmapheresis in Neurologic Disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 76:294-300, Cortese,I.,et al, 2011
Guillain-Barre Syndrome
BMJ 337:227-231, Winer,J.B., 2008
Plasma Exchange in Neuroimmunological Disorders: Part 2. Treatment of Neuromuscular Disorders
Arch Neurol 63:1066-1071, Lehmann,H.C.,et al, 2006
Guillain-Barre Syndrome
Lancet 366:1653-1666, Hughes,R.C. &Comblath,D.R., 2005
Practice Parameter:Immunotherapy for Guillain-Barre Syndrome, Report of the Quality Standards Subcommittee of the American Academy of Neurology
Neurol 61:736-740, Hughes,R.A.C.,et al, 2003
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Prognostic Factors of Guillain-Barre Syndrome After Intravenous Immunoglobulin or Plasma Exchange?
Neurol 53:598-604, Visser,L.H.,et al, 1999
Minimal Number of Plasma Exchanges Needed to Reduce Immunoglobulin in Guillain-Barre Syndrome
Neurol 51:875-877, Yuki,N.,et al, 1998
Morvan's Fibrillary Chorea: A Paraneoplastic Manifestation of Thymoma
JNNP 65:857-862, Lee,E.K.,et al, 1998
Appropriate Number of Plasma Exchanges in Guillain-Barre Syndrome
French Coop Grp on Plasma Exchange in GBS, Ann Neurol 41:298-306, 287997., , 1997
CIDP:Clinical Features & Responses to Trtm in 67 Consecutive Pts with/without a Monoclonal Gammopathy
Neurol 48:321-328, Gorson,K.G.,et al, 1997
Pilot Trial of Immunoglobulin Versus Plasma Exchange in Patients with Guillain-Barre Syndrome
Neurol 46:100-103, Bril,V.,et al, 1996
Campylobacter Jejuni Infection and Anti-GM1 Antibodies in Guillain-Barre Syndrome
Ann Neurol 40:181-187, Jacobs,B.C.,et al, 1996
Acute Paresis of Extraocular Muscles Associated with IgG Anti-GQ Antibody
Ann Neurol 39:668-672, Yuki,N., 1996
Chronic Inflammatory Demyelinating Polyradiculoneuropathy:Unusual Clinical Features and Therapeutic Responses
Neurol 46:1206-1212, Midroni,G.&Dyck,P.J., 1996
Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies
Ann Neurol 37:S63-S73, Sanders,D.B., 1995
Plasma Exchange and Intravenous Immunoglobulin Treatment of Neuromuscular Disease
Ann Neurol 35:260-268, Thornton,C.A.&Griggs,R.C., 1994
Relapse in Guillain-Barre Syndrome after Treatment with Human Immune Globulin
Neurol 43:872-875, 8571993., Inrani,D.N.,et al, 1993
Human Immune Globulin Infusion in Guillain-Barre Syndrome:Worsening During & After Treatment
Neurol 43:1034-1036, 8571993., Castro,L.H.M.&Ropper,A.H., 1993
Plasma Exchange In Guillain-Barre Syndrome:One-Year Follow-up
French Coop Group on Plasma Exchange in Guillain-Barre Syndrome, Ann Neurol 32:94-971992., , 1992
A Randomized Trial Comparins Intravenous Immune Globulin and Plasma Exchange in Guillain-Barre Syndrome
NEJM 326:1123-1129, VanDerMeche,F.G.A.,et al, 1992
Guillain-Barre Syndrome and Plasmapheresis in Childhood
(Letters) , Ann Neurol 29:688-68991., , 1991
CIDP of Childhood:Treatment with High-Dose Intravenous Immunoglobulin
Neurol 41:828-830, Vedanarayanan,V.V.,et al, 1991
Plasmapheresis in Children with Guillain-Barre Syndrome
Neurol 41:1928-1931, Lamont,P.J.,et al, 1991
Treatment Related Fluctuations in Guillain-Barre Syndrome after High-Dose Immunoglobulins or Plasma-Exchange
JNNP 54:957-960, Kleyweg,R.P.&van der Meche,F.G.A., 1991
The Role of Plasmapheresis in Childhood Guillain-Barre Syndrome
Ann Neurol 28:65-69, Epstein,M.A.&Sladky,J.T., 1990
Limited Relapse in Guillain-Barre Syndrome after Plasma Exchange
Arch Neurol 45:314-315, Ropper,A.H.,et al, 1988
Plasmapheresis and Guillain-Barre Syndrome:Analysis of Prognostic Factors & the Effect of Plasmapheresis
Ann Neurol 23:347-353, McKhann,G.M.,et al, 1988
Prediction of Early Beneficial Response to Plasma Exchange in Guillain-Barre Syndrome
Arch Neurol 44:295-298, Gruener,G.,et al, 1987
Guillain-Barre Syndrome:Quantitative Measurement of Plasma Exchange Therapy
Neurol 37:837-840, Farkkila,M.,et al, 1987
Efficiency of Plasma Exchange in Guillain-Barre Syndrome:Role of Replacement Fluids
French Cooperative Group, Ann Neurol 22:753-761, 762-763987., , 1987
Plasmapheresis & Acute Guillain-Barre Syndrome
The Guillain-Barre Syndrome Study Group, Neurol 35:1096-11041985., , 1985
Plasma Exchange & Prednisone in Guillain-Barre Syndrome:A Controlled Randomized Trial
Neurol 35:1551-1555, Mendell,J.R.,et al, 1985
Controlled Trial of Plasma Exchange in Acute Inflammatory Polyradiculoneuropathy
Lancet 1:877-879, Greenwood,R.J.,et al, 1984
Beneficial Effects of Plasma Exchange in Acute Inflammatory Polyradiculoneuropathy
Lancet 2:1296-1298, & 131384., Osterman,P.O.,et al, 1984
Treatment of the Guillain-Barre Syndrome by Plasma Exchange
JNNP 45:847-850, Kennard,C.,et al, 1982
Plasmapheresis in the Treatment of Four Cases of Guillain-Barre Syndrome (acute form)
Ital. J Neurol Sci 4:331-3361981., Zerbi,D.,et al, 1981
Guillain-Barre Syndrome:Is There a Role for Plasma-pheresis
Neurol 30:1112, Asbury,A.,et al, 1980
Treatment of Chronic Relapsing Inflammatory Polyradiculoneuropathy by Plasma Exchange
Ann Neurol 6:258-261, Server,A.C.,et al, 1979
Reversible Gait Ataxia
Neurol 88:e145-e149, Abkur, T.M. & Bede, P., 2017
Neuromyelitis Optica: Evaluation of 871 Attacks and 1,153 Treatment Courses
Ann Neurol 79:206-216,204, Kleiter, I.,et al, 2016
Diagnosis and Management of the Antiphospholipid Syndrome
BMJ 340:1125-1132, Cohen,D., et al, 2010